A Randomized Placebo-Controlled Phase 2 Study of Gemcitabine and Capecitabine with or without T-ChOS as Adjuvant Therapy in Patients with Resected Pancreatic Cancer (CHIPAC)

The antitumor activity of chitooligosaccharides has been suggested. This phase 2 trial evaluated the efficacy and safety of T-ChOS™, in addition to adjuvant chemotherapy, in patients after resection of pancreatic ductal adenocarcinoma (PDAC). In this single-center, randomized, double-blind, placebo-...

Descripción completa

Detalles Bibliográficos
Autores principales: Theile, Susann, Johansen, Julia Sidenius, Nielsen, Dorte Lisbet, Jensen, Benny Vittrup, Hansen, Carsten Palnæs, Hasselby, Jane Preuss, Eiríksson, Sverrir Vídalín, Chen, Inna Markovna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955369/
https://www.ncbi.nlm.nih.gov/pubmed/35335885
http://dx.doi.org/10.3390/pharmaceutics14030509

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955369/
https://www.ncbi.nlm.nih.gov/pubmed/35335885
http://dx.doi.org/10.3390/pharmaceutics14030509

Ejemplares similares